title: Testosterone topical solution (Axiron) for hypogonadism.
abstract: The Medical Letter recently reviewed a topical gel formulation of testosterone (Fortesta) for treatment of hypogonadism in men. A topical testosterone replacement product for application to the axilla, Axiron (Lilly) solution, has now become available for the same indication. This site of application presumably minimizes the risk of transferring the drug to a family member or sexual partner.
mesh_terms: D000287:Administration, Topical; D000818:Animals; D002986:Clinical Trials as Topic / Q000379:methods; D005076:Exanthema / Q000139:chemically induced; D006801:Humans; D007006:Hypogonadism / Q000188:drug therapy* / Q000378:metabolism; D008297:Male; D019999:Pharmaceutical Solutions / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D013739:Testosterone / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics
chemical_list: D019999:Pharmaceutical Solutions; D013739:Testosterone